CNS Pharmaceuticals to Participate in the Virtual Investor Summer Spotlight Series

Rhea-AI Summary

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) announced that its CEO and Chief Medical Officer will participate in the Virtual Investor Summer Spotlight Series on July 11th. The live video webcast will be available on the company's website, with a replay accessible for 90 days.

Live moderated video webcast on Tuesday, July 11^th at 12:00 PM ET

HOUSTON, TX / ACCESSWIRE / July 5, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer and Sandra L. Silberman, M.D., Ph.D., Chief Medical Officer of CNS Pharmaceuticals will participate in the Virtual Investor Summer Spotlight Series on Tuesday, July 11, 2023 at 12:00 PM ET.

A live video webcast of the event will be available on the Events page of the Investors section of the Company's website (cnspharma.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer.

For more information, please visit www.CNSPharma.com, and connect with the Company on Twitter, Facebook, and LinkedIn.

CONTACTS:

Investor Relations Contact

JTC Team, LLC
Jenene Thomas
833-475-8247
CNSP@jtcir.com

SOURCE: CNS Pharmaceuticals, Inc.

View source version on accesswire.com:
https://www.accesswire.com/765169/CNS-Pharmaceuticals-to-Participate-in-the-Virtual-Investor-Summer-Spotlight-Series

FAQ

What is the Virtual Investor Summer Spotlight Series?

The Virtual Investor Summer Spotlight Series is an event where companies present their updates and plans to investors.

When will the webcast take place?

The webcast will take place on Tuesday, July 11, 2023 at 12:00 PM ET.

Where can I watch the webcast?

The webcast will be available on the Events page of CNS Pharmaceuticals' website (cnspharma.com).

Will there be a replay of the webcast?

Yes, a webcast replay will be available two hours after the live presentation and will be accessible for 90 days.